Clinical Trials in Denver

Showing 3181-3200 of 15,604 trials

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

This clinical trial is evaluating a drug called AC676 in participants with Relapsed/Refractory B-cell Malignancies. The main goals of the study are to: * Identify the recommended dose of AC676 that can be given safely to participants * Evaluate the safety profile of AC676 * Evaluate the pharmacokinetics of AC676 * Evaluate the effectiveness of AC676

Relapsed/Refractory B-cell Malignancies

Accutar Biotechnology Inc60 participantsStarted Jun 2023

Denver, Colorado, United States • Sarasota, Florida, United States • Chapel Hill, North Carolina, United States +6 more locations

Active Not RecruitingPhase 1< 1 mile

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

A phase 1/2, first-in-human, open-label study of the safety, tolerability, PK, and efficacy of the novel MET/CSF1R/SRC inhibitor TPX-0022 in adult subjects with advanced or metastatic NSCLC, Gastric Cancer, or solid tumors harboring genetic alterations in MET. (SHIELD-I)

Advanced Solid TumorMetastatic Solid TumorsMET Gene Alterations

Turning Point Therapeutics, Inc.95 participantsStarted Sep 2019

La Jolla, California, United States • Orange, California, United States • Denver, Colorado, United States +21 more locations

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

Find Trials by Condition in Denver

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

AB-1005 Long-Term Follow-up Study